Taken together, these findings suggest that it is useful to consider ALP or BALP as a reliable marker for bone metabolism, but also as a predictor of CVD and mortality in CKD patients, while ALP may be a better mortality predictor than BALP in individuals without CKD. Here, ALPP is linked to chronic kidney disease.